Investor Alert

Aug. 7, 2020, 12:01 p.m. EDT

Injectable Drug Delivery Market Research Report by Assessment Type, by Component, by Application, by Vertical – Global Forecast to 2025 – Cumulative Impact of COVID-19

Watchlist Relevance

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Baxter International Inc. (BAX)
  • X
    Pfizer Inc. (PFE)
  • X
    Becton Dickinson & Co. (BDX)

or Cancel Already have a watchlist? Log In

7 Injectable Drug Delivery Market, By Type

8 Injectable Drug Delivery Market, By Formulation Packaging

9 Injectable Drug Delivery Market, By Therapeutic Application

10 Injectable Drug Delivery Market, By Usage Pattern

11 Injectable Drug Delivery Market, By Site of Administration

12 Injectable Drug Delivery Market, By Distribution Channel

13 Injectable Drug Delivery Market, By Facility of Use

14 Injectable Drug Delivery Market, By Region

15 Competitive Landscape

16 Company Profiles

16.1 Introduction

16.2 Baxter International, Inc.

16.3 Becton, Dickinson and Company

16.4 Gerresheimer AG

16.5 Pfizer, Inc.

16.6 Schott AG

16.7 ELI Lilly and Company

16.8 Sandoz (A Division of Novartis AG)

16.9 Terumo Corporation

16.10 Teva Pharmaceutical Industries Ltd.

Other Related Market Research Reports:

Influenza Diagnostics Market is Projected to Reach US$ 0.7674 Billion By 2024

India Sports Medicine Market is Supposed to Reach US$ 554 Million By 2022

In Vitro Diagnostics IVD Market is Expected To Be Worth US$ 77 Billion By 2024

Media Contact

Company Name: Market Research Engine

Contact Person: John Bay

Email: john@marketresearchengine.com

Phone: +1-855-984-1862

Country: United States

Website: https://www.marketresearchengine.com/


Is there a problem with this press release? Contact the source provider Comtex at editorial@comtex.com. You can also contact MarketWatch Customer Service via our Customer Center.

1 2
This Story has 0 Comments
Be the first to comment

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.